Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
NEUROGENESIS |
603 |
1402 |
6.654e-40 |
3.096e-36 |
2 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
684 |
1672 |
8.019e-37 |
1.866e-33 |
3 |
CELL DEVELOPMENT |
588 |
1426 |
1.287e-32 |
1.996e-29 |
4 |
REGULATION OF CELL DIFFERENTIATION |
608 |
1492 |
4.867e-32 |
5.599e-29 |
5 |
REGULATION OF CELL DEVELOPMENT |
383 |
836 |
6.016e-32 |
5.599e-29 |
6 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
445 |
1021 |
6.858e-31 |
5.318e-28 |
7 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
485 |
1142 |
2.177e-30 |
1.447e-27 |
8 |
REGULATION OF NEURON DIFFERENTIATION |
274 |
554 |
1.533e-29 |
8.917e-27 |
9 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
356 |
788 |
2.666e-28 |
1.241e-25 |
10 |
CIRCULATORY SYSTEM DEVELOPMENT |
356 |
788 |
2.666e-28 |
1.241e-25 |
11 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
340 |
750 |
2.173e-27 |
9.192e-25 |
12 |
RESPONSE TO ENDOGENOUS STIMULUS |
577 |
1450 |
3.134e-27 |
1.215e-24 |
13 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
428 |
1008 |
8.198e-27 |
2.934e-24 |
14 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
683 |
1784 |
1.09e-26 |
3.622e-24 |
15 |
INTRACELLULAR SIGNAL TRANSDUCTION |
613 |
1572 |
3.019e-26 |
9.365e-24 |
16 |
TISSUE DEVELOPMENT |
595 |
1518 |
4.031e-26 |
1.172e-23 |
17 |
ORGAN MORPHOGENESIS |
368 |
841 |
5.315e-26 |
1.455e-23 |
18 |
REGULATION OF CELL MORPHOGENESIS |
264 |
552 |
1.154e-25 |
2.982e-23 |
19 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
553 |
1395 |
1.273e-25 |
3.118e-23 |
20 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
360 |
823 |
2.04e-25 |
4.747e-23 |
21 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
181 |
337 |
4.112e-25 |
9.112e-23 |
22 |
REGULATION OF TRANSPORT |
682 |
1804 |
6.476e-25 |
1.37e-22 |
23 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
207 |
408 |
2.415e-24 |
4.886e-22 |
24 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
231 |
472 |
2.837e-24 |
5.5e-22 |
25 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
308 |
689 |
1.124e-23 |
2.091e-21 |
26 |
POSITIVE REGULATION OF GENE EXPRESSION |
653 |
1733 |
2.073e-23 |
3.711e-21 |
27 |
EMBRYO DEVELOPMENT |
378 |
894 |
2.424e-23 |
4.177e-21 |
28 |
HEAD DEVELOPMENT |
314 |
709 |
2.567e-23 |
4.266e-21 |
29 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
370 |
872 |
3.447e-23 |
5.53e-21 |
30 |
PROTEIN PHOSPHORYLATION |
394 |
944 |
4.81e-23 |
7.46e-21 |
31 |
NEURON DIFFERENTIATION |
370 |
874 |
5.62e-23 |
8.435e-21 |
32 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
242 |
513 |
1.356e-22 |
1.972e-20 |
33 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
667 |
1791 |
2.05e-22 |
2.821e-20 |
34 |
CELLULAR COMPONENT MORPHOGENESIS |
377 |
900 |
2.061e-22 |
2.821e-20 |
35 |
VASCULATURE DEVELOPMENT |
225 |
469 |
2.984e-22 |
3.968e-20 |
36 |
REGULATION OF CELL PROJECTION ORGANIZATION |
257 |
558 |
4.245e-22 |
5.486e-20 |
37 |
EMBRYONIC MORPHOGENESIS |
250 |
539 |
4.848e-22 |
6.097e-20 |
38 |
SKELETAL SYSTEM DEVELOPMENT |
219 |
455 |
6.494e-22 |
7.952e-20 |
39 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
622 |
1656 |
6.701e-22 |
7.995e-20 |
40 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
161 |
306 |
2.875e-21 |
3.344e-19 |
41 |
NEURON PROJECTION DEVELOPMENT |
250 |
545 |
3.107e-21 |
3.526e-19 |
42 |
NEURON DEVELOPMENT |
300 |
687 |
3.47e-21 |
3.844e-19 |
43 |
REGULATION OF CELLULAR LOCALIZATION |
496 |
1277 |
7.89e-21 |
8.537e-19 |
44 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
389 |
957 |
2.493e-20 |
2.636e-18 |
45 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
661 |
1805 |
3.753e-20 |
3.796e-18 |
46 |
CELL PROJECTION ORGANIZATION |
370 |
902 |
3.723e-20 |
3.796e-18 |
47 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
465 |
1192 |
5.606e-20 |
5.55e-18 |
48 |
POSITIVE REGULATION OF CELL COMMUNICATION |
574 |
1532 |
6.14e-20 |
5.952e-18 |
49 |
PHOSPHORYLATION |
476 |
1228 |
8.312e-20 |
7.893e-18 |
50 |
REGULATION OF DEVELOPMENTAL GROWTH |
151 |
289 |
1.18e-19 |
1.098e-17 |
51 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
568 |
1518 |
1.375e-19 |
1.254e-17 |
52 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
490 |
1275 |
1.623e-19 |
1.453e-17 |
53 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
206 |
437 |
2.29e-19 |
2.011e-17 |
54 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
669 |
1848 |
4.968e-19 |
4.281e-17 |
55 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
515 |
1360 |
5.628e-19 |
4.761e-17 |
56 |
RESPONSE TO GROWTH FACTOR |
218 |
475 |
1.062e-18 |
8.828e-17 |
57 |
NEURON PROJECTION MORPHOGENESIS |
189 |
402 |
1.005e-17 |
8.207e-16 |
58 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
442 |
1152 |
1.624e-17 |
1.303e-15 |
59 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
701 |
1977 |
1.749e-17 |
1.38e-15 |
60 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
515 |
1381 |
1.814e-17 |
1.407e-15 |
61 |
REGULATION OF AXONOGENESIS |
98 |
168 |
2.01e-17 |
1.533e-15 |
62 |
BLOOD VESSEL MORPHOGENESIS |
174 |
364 |
2.652e-17 |
1.991e-15 |
63 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
393 |
1004 |
2.829e-17 |
2.09e-15 |
64 |
REGULATION OF CELL PROLIFERATION |
550 |
1496 |
3.477e-17 |
2.528e-15 |
65 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
588 |
1618 |
3.882e-17 |
2.779e-15 |
66 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
315 |
771 |
5.24e-17 |
3.694e-15 |
67 |
REGULATION OF GROWTH |
268 |
633 |
6.416e-17 |
4.456e-15 |
68 |
REGULATION OF HYDROLASE ACTIVITY |
495 |
1327 |
7.76e-17 |
5.233e-15 |
69 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
304 |
740 |
7.741e-17 |
5.233e-15 |
70 |
REGULATION OF GTPASE ACTIVITY |
281 |
673 |
9.942e-17 |
6.608e-15 |
71 |
POSITIVE REGULATION OF TRANSPORT |
367 |
936 |
2.541e-16 |
1.665e-14 |
72 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
219 |
498 |
3.466e-16 |
2.24e-14 |
73 |
EMBRYONIC ORGAN DEVELOPMENT |
186 |
406 |
4.749e-16 |
3.027e-14 |
74 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
172 |
368 |
5.999e-16 |
3.722e-14 |
75 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
121 |
232 |
5.967e-16 |
3.722e-14 |
76 |
PROTEIN LOCALIZATION |
639 |
1805 |
8.786e-16 |
5.379e-14 |
77 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
309 |
767 |
1.014e-15 |
6.127e-14 |
78 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
609 |
1710 |
1.192e-15 |
7.11e-14 |
79 |
FOREBRAIN DEVELOPMENT |
167 |
357 |
1.445e-15 |
8.513e-14 |
80 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
319 |
799 |
1.475e-15 |
8.576e-14 |
81 |
BIOLOGICAL ADHESION |
395 |
1032 |
1.503e-15 |
8.635e-14 |
82 |
TISSUE MORPHOGENESIS |
229 |
533 |
1.766e-15 |
1.002e-13 |
83 |
CELL PART MORPHOGENESIS |
263 |
633 |
2.015e-15 |
1.13e-13 |
84 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
539 |
1492 |
3.405e-15 |
1.886e-13 |
85 |
NEGATIVE REGULATION OF GENE EXPRESSION |
539 |
1493 |
3.923e-15 |
2.148e-13 |
86 |
SENSORY ORGAN DEVELOPMENT |
214 |
493 |
4.091e-15 |
2.214e-13 |
87 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
146 |
303 |
4.214e-15 |
2.254e-13 |
88 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
235 |
554 |
4.263e-15 |
2.254e-13 |
89 |
LOCOMOTION |
419 |
1114 |
5.093e-15 |
2.663e-13 |
90 |
HEART DEVELOPMENT |
204 |
466 |
6.38e-15 |
3.298e-13 |
91 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
351 |
905 |
7.346e-15 |
3.756e-13 |
92 |
TUBE DEVELOPMENT |
233 |
552 |
1.074e-14 |
5.433e-13 |
93 |
EMBRYONIC ORGAN MORPHOGENESIS |
136 |
279 |
1.164e-14 |
5.826e-13 |
94 |
SINGLE ORGANISM BEHAVIOR |
174 |
384 |
1.469e-14 |
7.271e-13 |
95 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
669 |
1929 |
2.325e-14 |
1.139e-12 |
96 |
RESPONSE TO HORMONE |
345 |
893 |
2.373e-14 |
1.14e-12 |
97 |
TELENCEPHALON DEVELOPMENT |
116 |
228 |
2.376e-14 |
1.14e-12 |
98 |
REGULATION OF PROTEIN LOCALIZATION |
363 |
950 |
3.014e-14 |
1.431e-12 |
99 |
MODULATION OF SYNAPTIC TRANSMISSION |
143 |
301 |
3.39e-14 |
1.593e-12 |
100 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
137 |
285 |
3.717e-14 |
1.73e-12 |
101 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
314 |
801 |
4.212e-14 |
1.941e-12 |
102 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
134 |
278 |
5.435e-14 |
2.479e-12 |
103 |
BEHAVIOR |
218 |
516 |
7.012e-14 |
3.168e-12 |
104 |
UROGENITAL SYSTEM DEVELOPMENT |
141 |
299 |
1.061e-13 |
4.749e-12 |
105 |
EPITHELIUM DEVELOPMENT |
359 |
945 |
1.075e-13 |
4.765e-12 |
106 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
116 |
232 |
1.133e-13 |
4.971e-12 |
107 |
MORPHOGENESIS OF AN EPITHELIUM |
177 |
400 |
1.243e-13 |
5.404e-12 |
108 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
202 |
472 |
1.313e-13 |
5.658e-12 |
109 |
CONNECTIVE TISSUE DEVELOPMENT |
101 |
194 |
1.731e-13 |
7.39e-12 |
110 |
REGULATION OF KINASE ACTIVITY |
303 |
776 |
2.125e-13 |
8.989e-12 |
111 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
114 |
229 |
2.69e-13 |
1.128e-11 |
112 |
TUBE MORPHOGENESIS |
148 |
323 |
4.637e-13 |
1.926e-11 |
113 |
REGULATION OF CELLULAR COMPONENT SIZE |
153 |
337 |
4.707e-13 |
1.938e-11 |
114 |
CELL MOTILITY |
320 |
835 |
7.095e-13 |
2.871e-11 |
115 |
LOCALIZATION OF CELL |
320 |
835 |
7.095e-13 |
2.871e-11 |
116 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
534 |
1517 |
8.566e-13 |
3.436e-11 |
117 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
367 |
983 |
9.078e-13 |
3.61e-11 |
118 |
SKELETAL SYSTEM MORPHOGENESIS |
102 |
201 |
1.054e-12 |
4.157e-11 |
119 |
REGULATION OF MEMBRANE POTENTIAL |
154 |
343 |
1.188e-12 |
4.606e-11 |
120 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
226 |
552 |
1.184e-12 |
4.606e-11 |
121 |
REGULATION OF CELL CYCLE |
355 |
949 |
1.627e-12 |
6.256e-11 |
122 |
GROWTH |
177 |
410 |
1.747e-12 |
6.662e-11 |
123 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
70 |
122 |
2.226e-12 |
8.422e-11 |
124 |
POSITIVE REGULATION OF CELL PROLIFERATION |
311 |
814 |
2.33e-12 |
8.742e-11 |
125 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
139 |
304 |
2.871e-12 |
1.069e-10 |
126 |
ANGIOGENESIS |
135 |
293 |
2.973e-12 |
1.098e-10 |
127 |
VESICLE MEDIATED TRANSPORT |
445 |
1239 |
3.031e-12 |
1.11e-10 |
128 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
103 |
207 |
3.882e-12 |
1.411e-10 |
129 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
224 |
552 |
4.24e-12 |
1.529e-10 |
130 |
PALLIUM DEVELOPMENT |
82 |
153 |
4.406e-12 |
1.577e-10 |
131 |
REGULATION OF CELL DEATH |
516 |
1472 |
4.703e-12 |
1.671e-10 |
132 |
POSITIVE REGULATION OF KINASE ACTIVITY |
200 |
482 |
5.634e-12 |
1.986e-10 |
133 |
REGULATION OF SECRETION |
272 |
699 |
5.834e-12 |
2.041e-10 |
134 |
EAR DEVELOPMENT |
98 |
195 |
6.087e-12 |
2.114e-10 |
135 |
PATTERN SPECIFICATION PROCESS |
178 |
418 |
6.249e-12 |
2.154e-10 |
136 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
155 |
352 |
6.581e-12 |
2.252e-10 |
137 |
STEM CELL DIFFERENTIATION |
96 |
190 |
6.698e-12 |
2.275e-10 |
138 |
RESPONSE TO NITROGEN COMPOUND |
323 |
859 |
8.405e-12 |
2.834e-10 |
139 |
CARTILAGE DEVELOPMENT |
79 |
147 |
8.98e-12 |
3.006e-10 |
140 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
207 |
505 |
9.318e-12 |
3.097e-10 |
141 |
REGULATION OF CELL GROWTH |
168 |
391 |
1.022e-11 |
3.371e-10 |
142 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
378 |
1036 |
1.453e-11 |
4.727e-10 |
143 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
378 |
1036 |
1.453e-11 |
4.727e-10 |
144 |
REGULATION OF NEUROTRANSMITTER LEVELS |
95 |
190 |
1.851e-11 |
5.98e-10 |
145 |
MUSCLE STRUCTURE DEVELOPMENT |
181 |
432 |
2.182e-11 |
7.002e-10 |
146 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
84 |
162 |
2.422e-11 |
7.718e-10 |
147 |
RESPONSE TO ABIOTIC STIMULUS |
373 |
1024 |
2.557e-11 |
8.094e-10 |
148 |
CEREBRAL CORTEX DEVELOPMENT |
61 |
105 |
2.77e-11 |
8.708e-10 |
149 |
COGNITION |
117 |
251 |
3.299e-11 |
1.03e-09 |
150 |
REGULATION OF SYNAPTIC PLASTICITY |
75 |
140 |
3.665e-11 |
1.137e-09 |
151 |
DEVELOPMENTAL GROWTH |
146 |
333 |
3.936e-11 |
1.213e-09 |
152 |
REGULATION OF STEM CELL DIFFERENTIATION |
64 |
113 |
4.18e-11 |
1.279e-09 |
153 |
RESPONSE TO ALCOHOL |
156 |
362 |
4.251e-11 |
1.293e-09 |
154 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
572 |
1676 |
5.045e-11 |
1.519e-09 |
155 |
APPENDAGE DEVELOPMENT |
86 |
169 |
5.092e-11 |
1.519e-09 |
156 |
LIMB DEVELOPMENT |
86 |
169 |
5.092e-11 |
1.519e-09 |
157 |
REGULATION OF CELL SIZE |
87 |
172 |
5.939e-11 |
1.76e-09 |
158 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
85 |
167 |
6.488e-11 |
1.911e-09 |
159 |
CYTOSKELETON ORGANIZATION |
312 |
838 |
7.207e-11 |
2.109e-09 |
160 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
55 |
93 |
1e-10 |
2.909e-09 |
161 |
CELLULAR MACROMOLECULE LOCALIZATION |
435 |
1234 |
1.099e-10 |
3.175e-09 |
162 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
404 |
1135 |
1.282e-10 |
3.683e-09 |
163 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
170 |
408 |
1.486e-10 |
4.243e-09 |
164 |
REGULATION OF EXTENT OF CELL GROWTH |
58 |
101 |
1.6e-10 |
4.539e-09 |
165 |
CELLULAR RESPONSE TO STRESS |
535 |
1565 |
1.731e-10 |
4.881e-09 |
166 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
79 |
154 |
1.853e-10 |
5.194e-09 |
167 |
REGULATION OF CYTOPLASMIC TRANSPORT |
194 |
481 |
2.147e-10 |
5.982e-09 |
168 |
REGIONALIZATION |
136 |
311 |
2.254e-10 |
6.243e-09 |
169 |
NEURON PROJECTION GUIDANCE |
98 |
205 |
2.28e-10 |
6.256e-09 |
170 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
168 |
404 |
2.286e-10 |
6.256e-09 |
171 |
PROTEIN AUTOPHOSPHORYLATION |
93 |
192 |
2.705e-10 |
7.36e-09 |
172 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
90 |
184 |
2.744e-10 |
7.423e-09 |
173 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
43 |
67 |
2.795e-10 |
7.517e-09 |
174 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
334 |
917 |
2.982e-10 |
7.974e-09 |
175 |
REGULATION OF TRANSFERASE ACTIVITY |
343 |
946 |
3.133e-10 |
8.293e-09 |
176 |
REGULATION OF CELL ADHESION |
242 |
629 |
3.137e-10 |
8.293e-09 |
177 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
188 |
465 |
3.233e-10 |
8.498e-09 |
178 |
CELL CELL SIGNALING |
286 |
767 |
3.806e-10 |
9.949e-09 |
179 |
REGULATION OF CYTOSKELETON ORGANIZATION |
200 |
502 |
3.896e-10 |
1.013e-08 |
180 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
79 |
156 |
4.133e-10 |
1.068e-08 |
181 |
REGULATION OF OSSIFICATION |
87 |
178 |
5.674e-10 |
1.459e-08 |
182 |
REGULATION OF SYSTEM PROCESS |
201 |
507 |
5.744e-10 |
1.469e-08 |
183 |
ACTIN FILAMENT BASED PROCESS |
182 |
450 |
5.983e-10 |
1.521e-08 |
184 |
MESENCHYMAL CELL DIFFERENTIATION |
70 |
134 |
7.079e-10 |
1.79e-08 |
185 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
319 |
876 |
7.794e-10 |
1.96e-08 |
186 |
GLAND DEVELOPMENT |
163 |
395 |
8.33e-10 |
2.084e-08 |
187 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
91 |
190 |
8.755e-10 |
2.179e-08 |
188 |
PALATE DEVELOPMENT |
50 |
85 |
9.134e-10 |
2.261e-08 |
189 |
CHEMICAL HOMEOSTASIS |
318 |
874 |
9.229e-10 |
2.272e-08 |
190 |
POSITIVE REGULATION OF LOCOMOTION |
171 |
420 |
1.091e-09 |
2.672e-08 |
191 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
186 |
465 |
1.103e-09 |
2.686e-08 |
192 |
REGULATION OF ORGANELLE ORGANIZATION |
412 |
1178 |
1.115e-09 |
2.702e-08 |
193 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
244 |
643 |
1.2e-09 |
2.892e-08 |
194 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
233 |
609 |
1.214e-09 |
2.911e-08 |
195 |
SYNAPTIC SIGNALING |
172 |
424 |
1.353e-09 |
3.227e-08 |
196 |
CELL CELL ADHESION |
232 |
608 |
1.738e-09 |
4.125e-08 |
197 |
CELL CYCLE |
453 |
1316 |
1.787e-09 |
4.222e-08 |
198 |
CELL DEATH |
356 |
1001 |
1.916e-09 |
4.503e-08 |
199 |
REGULATION OF INTRACELLULAR TRANSPORT |
236 |
621 |
1.927e-09 |
4.505e-08 |
200 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
49 |
84 |
1.996e-09 |
4.62e-08 |
201 |
POSITIVE REGULATION OF OSSIFICATION |
49 |
84 |
1.996e-09 |
4.62e-08 |
202 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
184 |
462 |
2.017e-09 |
4.645e-08 |
203 |
HOMEOSTATIC PROCESS |
459 |
1337 |
2.068e-09 |
4.74e-08 |
204 |
OSSIFICATION |
112 |
251 |
2.112e-09 |
4.816e-08 |
205 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
485 |
1423 |
2.151e-09 |
4.877e-08 |
206 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
256 |
684 |
2.159e-09 |
4.877e-08 |
207 |
REGULATION OF MAPK CASCADE |
248 |
660 |
2.534e-09 |
5.696e-08 |
208 |
RESPONSE TO LIPID |
320 |
888 |
2.688e-09 |
6.014e-08 |
209 |
POSITIVE REGULATION OF GROWTH |
107 |
238 |
2.877e-09 |
6.406e-08 |
210 |
RHYTHMIC PROCESS |
128 |
298 |
2.959e-09 |
6.557e-08 |
211 |
REGULATION OF WNT SIGNALING PATHWAY |
132 |
310 |
3.279e-09 |
7.231e-08 |
212 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
91 |
194 |
3.297e-09 |
7.236e-08 |
213 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
209 |
541 |
3.439e-09 |
7.478e-08 |
214 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
209 |
541 |
3.439e-09 |
7.478e-08 |
215 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
233 |
616 |
3.957e-09 |
8.564e-08 |
216 |
RESPONSE TO OXYGEN LEVELS |
132 |
311 |
4.182e-09 |
9.008e-08 |
217 |
HEART MORPHOGENESIS |
97 |
212 |
5.14e-09 |
1.102e-07 |
218 |
MEMORY |
54 |
98 |
5.198e-09 |
1.109e-07 |
219 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
132 |
312 |
5.321e-09 |
1.12e-07 |
220 |
MESENCHYME DEVELOPMENT |
89 |
190 |
5.316e-09 |
1.12e-07 |
221 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
185 |
470 |
5.289e-09 |
1.12e-07 |
222 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
63 |
121 |
5.861e-09 |
1.228e-07 |
223 |
ACTION POTENTIAL |
52 |
94 |
8.286e-09 |
1.729e-07 |
224 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
227 |
602 |
8.526e-09 |
1.771e-07 |
225 |
EPITHELIAL CELL DEVELOPMENT |
87 |
186 |
8.569e-09 |
1.772e-07 |
226 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
42 |
70 |
8.784e-09 |
1.808e-07 |
227 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
512 |
1527 |
9.735e-09 |
1.995e-07 |
228 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
128 |
303 |
1.006e-08 |
2.053e-07 |
229 |
MEMBRANE DEPOLARIZATION |
38 |
61 |
1.03e-08 |
2.088e-07 |
230 |
MUSCLE ORGAN DEVELOPMENT |
119 |
277 |
1.037e-08 |
2.088e-07 |
231 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
99 |
220 |
1.043e-08 |
2.088e-07 |
232 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
168 |
422 |
1.04e-08 |
2.088e-07 |
233 |
INNER EAR MORPHOGENESIS |
51 |
92 |
1.046e-08 |
2.088e-07 |
234 |
REGULATION OF CELL SUBSTRATE ADHESION |
82 |
173 |
1.068e-08 |
2.124e-07 |
235 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
378 |
1087 |
1.188e-08 |
2.353e-07 |
236 |
REGULATION OF NEURON DEATH |
110 |
252 |
1.299e-08 |
2.561e-07 |
237 |
RESPONSE TO ESTROGEN |
98 |
218 |
1.317e-08 |
2.578e-07 |
238 |
REGULATION OF CELL MATRIX ADHESION |
50 |
90 |
1.319e-08 |
2.578e-07 |
239 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
71 |
144 |
1.327e-08 |
2.583e-07 |
240 |
REGULATION OF CATABOLIC PROCESS |
267 |
731 |
1.409e-08 |
2.731e-07 |
241 |
RESPONSE TO STEROID HORMONE |
192 |
497 |
1.487e-08 |
2.871e-07 |
242 |
NEGATIVE REGULATION OF CELL DEATH |
311 |
872 |
1.514e-08 |
2.911e-07 |
243 |
EYE DEVELOPMENT |
135 |
326 |
1.778e-08 |
3.404e-07 |
244 |
SENSORY ORGAN MORPHOGENESIS |
105 |
239 |
1.825e-08 |
3.481e-07 |
245 |
RESPONSE TO DRUG |
170 |
431 |
1.845e-08 |
3.505e-07 |
246 |
SECRETION BY CELL |
188 |
486 |
1.868e-08 |
3.534e-07 |
247 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
74 |
153 |
1.882e-08 |
3.545e-07 |
248 |
SYNAPSE ORGANIZATION |
71 |
145 |
1.911e-08 |
3.585e-07 |
249 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
25 |
34 |
2.508e-08 |
4.687e-07 |
250 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
55 |
104 |
2.619e-08 |
4.874e-07 |
251 |
POST EMBRYONIC DEVELOPMENT |
49 |
89 |
2.724e-08 |
5.05e-07 |
252 |
EAR MORPHOGENESIS |
58 |
112 |
2.993e-08 |
5.526e-07 |
253 |
DEVELOPMENTAL MATURATION |
88 |
193 |
3.168e-08 |
5.827e-07 |
254 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
171 |
437 |
3.227e-08 |
5.911e-07 |
255 |
POSITIVE REGULATION OF CELL DEATH |
225 |
605 |
3.721e-08 |
6.79e-07 |
256 |
NEGATIVE REGULATION OF GROWTH |
103 |
236 |
3.752e-08 |
6.82e-07 |
257 |
REGULATION OF HOMEOSTATIC PROCESS |
174 |
447 |
3.77e-08 |
6.826e-07 |
258 |
MULTICELLULAR ORGANISMAL SIGNALING |
62 |
123 |
3.8e-08 |
6.854e-07 |
259 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
112 |
262 |
3.836e-08 |
6.891e-07 |
260 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
78 |
166 |
3.869e-08 |
6.923e-07 |
261 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
89 |
197 |
4.517e-08 |
8.052e-07 |
262 |
NEGATIVE REGULATION OF CELL CYCLE |
169 |
433 |
4.764e-08 |
8.461e-07 |
263 |
SECRETION |
219 |
588 |
4.935e-08 |
8.731e-07 |
264 |
PLASMA MEMBRANE ORGANIZATION |
91 |
203 |
5.037e-08 |
8.878e-07 |
265 |
TAXIS |
179 |
464 |
5.099e-08 |
8.953e-07 |
266 |
REGULATION OF ION TRANSPORT |
220 |
592 |
5.643e-08 |
9.872e-07 |
267 |
PEPTIDYL AMINO ACID MODIFICATION |
298 |
841 |
6.178e-08 |
1.075e-06 |
268 |
FAT CELL DIFFERENTIATION |
55 |
106 |
6.192e-08 |
1.075e-06 |
269 |
RESPONSE TO PEPTIDE |
159 |
404 |
6.251e-08 |
1.081e-06 |
270 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
156 |
395 |
6.377e-08 |
1.099e-06 |
271 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
117 |
279 |
6.888e-08 |
1.183e-06 |
272 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
227 |
616 |
7.629e-08 |
1.305e-06 |
273 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
261 |
724 |
7.75e-08 |
1.321e-06 |
274 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
59 |
117 |
7.888e-08 |
1.34e-06 |
275 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
37 |
62 |
8.17e-08 |
1.382e-06 |
276 |
PEPTIDYL THREONINE MODIFICATION |
30 |
46 |
8.198e-08 |
1.382e-06 |
277 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
52 |
99 |
8.355e-08 |
1.398e-06 |
278 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
52 |
99 |
8.355e-08 |
1.398e-06 |
279 |
BODY MORPHOGENESIS |
29 |
44 |
9.543e-08 |
1.591e-06 |
280 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
314 |
898 |
1.183e-07 |
1.966e-06 |
281 |
CELLULAR RESPONSE TO LIPID |
175 |
457 |
1.293e-07 |
2.141e-06 |
282 |
PEPTIDYL SERINE MODIFICATION |
70 |
148 |
1.371e-07 |
2.262e-06 |
283 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
90 |
204 |
1.461e-07 |
2.403e-06 |
284 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
249 |
691 |
1.605e-07 |
2.629e-06 |
285 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
85 |
191 |
2.023e-07 |
3.302e-06 |
286 |
MUSCLE TISSUE DEVELOPMENT |
114 |
275 |
2.079e-07 |
3.382e-06 |
287 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
164 |
426 |
2.136e-07 |
3.464e-06 |
288 |
REGULATION OF EPITHELIAL CELL MIGRATION |
76 |
166 |
2.178e-07 |
3.518e-06 |
289 |
REGULATION OF DENDRITE DEVELOPMENT |
59 |
120 |
2.453e-07 |
3.95e-06 |
290 |
RESPONSE TO BMP |
49 |
94 |
2.654e-07 |
4.243e-06 |
291 |
CELLULAR RESPONSE TO BMP STIMULUS |
49 |
94 |
2.654e-07 |
4.243e-06 |
292 |
REGULATION OF NEURON APOPTOTIC PROCESS |
85 |
192 |
2.668e-07 |
4.251e-06 |
293 |
WNT SIGNALING PATHWAY |
139 |
351 |
2.712e-07 |
4.307e-06 |
294 |
CELLULAR RESPONSE TO ALCOHOL |
57 |
115 |
2.759e-07 |
4.367e-06 |
295 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
94 |
218 |
2.856e-07 |
4.504e-06 |
296 |
LOCOMOTORY BEHAVIOR |
81 |
181 |
2.913e-07 |
4.579e-06 |
297 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
52 |
102 |
2.923e-07 |
4.579e-06 |
298 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
55 |
110 |
3.079e-07 |
4.807e-06 |
299 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
26 |
39 |
3.147e-07 |
4.865e-06 |
300 |
TRABECULA MORPHOGENESIS |
26 |
39 |
3.147e-07 |
4.865e-06 |
301 |
ENDOCYTOSIS |
190 |
509 |
3.142e-07 |
4.865e-06 |
302 |
CELLULAR RESPONSE TO PEPTIDE |
113 |
274 |
3.217e-07 |
4.956e-06 |
303 |
REGULATION OF JNK CASCADE |
73 |
159 |
3.268e-07 |
5.019e-06 |
304 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
100 |
236 |
3.33e-07 |
5.097e-06 |
305 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
70 |
151 |
3.595e-07 |
5.484e-06 |
306 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
67 |
143 |
3.902e-07 |
5.934e-06 |
307 |
IN UTERO EMBRYONIC DEVELOPMENT |
125 |
311 |
4.195e-07 |
6.358e-06 |
308 |
RESPONSE TO ESTRADIOL |
68 |
146 |
4.228e-07 |
6.388e-06 |
309 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
52 |
103 |
4.348e-07 |
6.547e-06 |
310 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
13 |
14 |
4.687e-07 |
7.035e-06 |
311 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
156 |
406 |
4.801e-07 |
7.183e-06 |
312 |
REGULATION OF EXOCYTOSIS |
82 |
186 |
5.314e-07 |
7.925e-06 |
313 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
67 |
144 |
5.369e-07 |
7.981e-06 |
314 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
33 |
56 |
6.148e-07 |
9.111e-06 |
315 |
REGULATION OF BINDING |
115 |
283 |
6.244e-07 |
9.223e-06 |
316 |
RESPONSE TO INORGANIC SUBSTANCE |
179 |
479 |
6.292e-07 |
9.264e-06 |
317 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
55 |
112 |
6.502e-07 |
9.544e-06 |
318 |
LEARNING |
62 |
131 |
6.754e-07 |
9.883e-06 |
319 |
RESPONSE TO EXTERNAL STIMULUS |
585 |
1821 |
7.059e-07 |
1.03e-05 |
320 |
SIGNAL RELEASE |
77 |
173 |
7.363e-07 |
1.071e-05 |
321 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
147 |
381 |
7.686e-07 |
1.107e-05 |
322 |
PROTEIN UBIQUITINATION |
226 |
629 |
7.641e-07 |
1.107e-05 |
323 |
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS |
29 |
47 |
7.671e-07 |
1.107e-05 |
324 |
RESPONSE TO INSULIN |
88 |
205 |
8.492e-07 |
1.219e-05 |
325 |
RESPONSE TO CARBOHYDRATE |
75 |
168 |
8.842e-07 |
1.266e-05 |
326 |
HEAD MORPHOGENESIS |
24 |
36 |
9.018e-07 |
1.287e-05 |
327 |
GLAND MORPHOGENESIS |
49 |
97 |
9.049e-07 |
1.288e-05 |
328 |
POSITIVE REGULATION OF AXONOGENESIS |
38 |
69 |
9.581e-07 |
1.359e-05 |
329 |
CELL DIVISION |
172 |
460 |
9.923e-07 |
1.403e-05 |
330 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
50 |
100 |
1.044e-06 |
1.473e-05 |
331 |
PROTEIN COMPLEX BIOGENESIS |
379 |
1132 |
1.077e-06 |
1.509e-05 |
332 |
PROTEIN COMPLEX ASSEMBLY |
379 |
1132 |
1.077e-06 |
1.509e-05 |
333 |
POSITIVE REGULATION OF MAPK CASCADE |
175 |
470 |
1.093e-06 |
1.527e-05 |
334 |
RESPONSE TO ACID CHEMICAL |
126 |
319 |
1.128e-06 |
1.571e-05 |
335 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
48 |
95 |
1.156e-06 |
1.605e-05 |
336 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
65 |
141 |
1.182e-06 |
1.636e-05 |
337 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
92 |
218 |
1.192e-06 |
1.646e-05 |
338 |
CELLULAR RESPONSE TO ACID CHEMICAL |
77 |
175 |
1.275e-06 |
1.756e-05 |
339 |
REGULATION OF VASCULATURE DEVELOPMENT |
97 |
233 |
1.294e-06 |
1.776e-05 |
340 |
POSITIVE REGULATION OF ION TRANSPORT |
98 |
236 |
1.311e-06 |
1.794e-05 |
341 |
REGULATION OF ORGAN MORPHOGENESIS |
100 |
242 |
1.342e-06 |
1.831e-05 |
342 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
32 |
55 |
1.348e-06 |
1.833e-05 |
343 |
KIDNEY EPITHELIUM DEVELOPMENT |
59 |
125 |
1.392e-06 |
1.888e-05 |
344 |
LONG TERM MEMORY |
20 |
28 |
1.4e-06 |
1.891e-05 |
345 |
ION HOMEOSTASIS |
208 |
576 |
1.402e-06 |
1.891e-05 |
346 |
CIRCULATORY SYSTEM PROCESS |
141 |
366 |
1.411e-06 |
1.898e-05 |
347 |
SEX DIFFERENTIATION |
108 |
266 |
1.417e-06 |
1.9e-05 |
348 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
34 |
60 |
1.471e-06 |
1.967e-05 |
349 |
RESPONSE TO STEROL |
18 |
24 |
1.506e-06 |
2.008e-05 |
350 |
CELLULAR HOMEOSTASIS |
239 |
676 |
1.522e-06 |
2.023e-05 |
351 |
NEGATIVE REGULATION OF CELL GROWTH |
75 |
170 |
1.539e-06 |
2.034e-05 |
352 |
NEGATIVE REGULATION OF AXONOGENESIS |
36 |
65 |
1.535e-06 |
2.034e-05 |
353 |
REGULATION OF LIPID METABOLIC PROCESS |
113 |
282 |
1.753e-06 |
2.31e-05 |
354 |
REGULATION OF ORGAN GROWTH |
39 |
73 |
1.931e-06 |
2.538e-05 |
355 |
CELL PROLIFERATION |
237 |
672 |
2.071e-06 |
2.707e-05 |
356 |
RESPIRATORY SYSTEM DEVELOPMENT |
84 |
197 |
2.069e-06 |
2.707e-05 |
357 |
NEURON MIGRATION |
53 |
110 |
2.159e-06 |
2.814e-05 |
358 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
57 |
121 |
2.254e-06 |
2.921e-05 |
359 |
REGULATION OF PEPTIDE SECRETION |
88 |
209 |
2.254e-06 |
2.921e-05 |
360 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
66 |
146 |
2.296e-06 |
2.967e-05 |
361 |
REGULATION OF PROTEIN IMPORT |
79 |
183 |
2.317e-06 |
2.987e-05 |
362 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
32 |
56 |
2.325e-06 |
2.988e-05 |
363 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
29 |
49 |
2.599e-06 |
3.327e-05 |
364 |
PROTEIN HOMOOLIGOMERIZATION |
101 |
248 |
2.603e-06 |
3.327e-05 |
365 |
NEGATIVE REGULATION OF LOCOMOTION |
106 |
263 |
2.639e-06 |
3.34e-05 |
366 |
REGULATION OF TRANSPORTER ACTIVITY |
84 |
198 |
2.642e-06 |
3.34e-05 |
367 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
75 |
172 |
2.629e-06 |
3.34e-05 |
368 |
PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION |
55 |
116 |
2.625e-06 |
3.34e-05 |
369 |
ION TRANSPORT |
415 |
1262 |
2.68e-06 |
3.379e-05 |
370 |
NEUROTRANSMITTER TRANSPORT |
69 |
155 |
2.687e-06 |
3.379e-05 |
371 |
DENDRITE DEVELOPMENT |
41 |
79 |
2.842e-06 |
3.565e-05 |
372 |
CARDIAC CHAMBER DEVELOPMENT |
65 |
144 |
2.903e-06 |
3.631e-05 |
373 |
TRANSMISSION OF NERVE IMPULSE |
31 |
54 |
2.918e-06 |
3.64e-05 |
374 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
53 |
111 |
3.044e-06 |
3.787e-05 |
375 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
50 |
103 |
3.156e-06 |
3.915e-05 |
376 |
REGULATION OF METAL ION TRANSPORT |
126 |
325 |
3.458e-06 |
4.279e-05 |
377 |
CELL CYCLE PROCESS |
360 |
1081 |
3.521e-06 |
4.346e-05 |
378 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
87 |
208 |
3.543e-06 |
4.362e-05 |
379 |
ORGANELLE LOCALIZATION |
155 |
415 |
3.592e-06 |
4.41e-05 |
380 |
TRANSMEMBRANE TRANSPORT |
365 |
1098 |
3.634e-06 |
4.449e-05 |
381 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
19 |
27 |
3.708e-06 |
4.529e-05 |
382 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
114 |
289 |
3.843e-06 |
4.681e-05 |
383 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
60 |
131 |
3.876e-06 |
4.708e-05 |
384 |
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS |
56 |
120 |
3.961e-06 |
4.799e-05 |
385 |
POSITIVE REGULATION OF CELL CYCLE |
128 |
332 |
4.038e-06 |
4.881e-05 |
386 |
POSITIVE REGULATION OF CELL GROWTH |
66 |
148 |
4.073e-06 |
4.91e-05 |
387 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
137 |
360 |
4.222e-06 |
5.076e-05 |
388 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
29 |
50 |
4.58e-06 |
5.479e-05 |
389 |
FACE DEVELOPMENT |
29 |
50 |
4.58e-06 |
5.479e-05 |
390 |
POSITIVE REGULATION OF AUTOPHAGY |
39 |
75 |
4.635e-06 |
5.53e-05 |
391 |
REGULATED EXOCYTOSIS |
92 |
224 |
4.707e-06 |
5.602e-05 |
392 |
IMMUNE SYSTEM DEVELOPMENT |
207 |
582 |
4.806e-06 |
5.704e-05 |
393 |
REGULATION OF RESPONSE TO STRESS |
474 |
1468 |
4.83e-06 |
5.719e-05 |
394 |
RAS PROTEIN SIGNAL TRANSDUCTION |
64 |
143 |
4.891e-06 |
5.776e-05 |
395 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
22 |
34 |
5.451e-06 |
6.421e-05 |
396 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
61 |
135 |
5.55e-06 |
6.521e-05 |
397 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
62 |
138 |
5.864e-06 |
6.873e-05 |
398 |
REGULATION OF MAP KINASE ACTIVITY |
123 |
319 |
6.134e-06 |
7.172e-05 |
399 |
REGULATION OF CELL JUNCTION ASSEMBLY |
36 |
68 |
6.253e-06 |
7.292e-05 |
400 |
MITOTIC CELL CYCLE |
263 |
766 |
6.288e-06 |
7.314e-05 |
401 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
81 |
193 |
6.477e-06 |
7.497e-05 |
402 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
141 |
375 |
6.476e-06 |
7.497e-05 |
403 |
CELL SUBSTRATE ADHESION |
71 |
164 |
6.514e-06 |
7.521e-05 |
404 |
EPITHELIAL CELL DIFFERENTIATION |
179 |
495 |
6.757e-06 |
7.783e-05 |
405 |
REGULATION OF HORMONE SECRETION |
104 |
262 |
7.249e-06 |
8.328e-05 |
406 |
REGULATION OF PEPTIDE TRANSPORT |
102 |
256 |
7.301e-06 |
8.347e-05 |
407 |
LIMBIC SYSTEM DEVELOPMENT |
48 |
100 |
7.291e-06 |
8.347e-05 |
408 |
LONG TERM SYNAPTIC POTENTIATION |
24 |
39 |
7.385e-06 |
8.422e-05 |
409 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
49 |
103 |
8.037e-06 |
9.143e-05 |
410 |
CELLULAR CHEMICAL HOMEOSTASIS |
202 |
570 |
8.121e-06 |
9.217e-05 |
411 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
82 |
197 |
8.295e-06 |
9.391e-05 |
412 |
VESICLE LOCALIZATION |
91 |
224 |
8.942e-06 |
0.000101 |
413 |
REGULATION OF DENDRITE MORPHOGENESIS |
38 |
74 |
8.988e-06 |
0.0001011 |
414 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
23 |
37 |
8.995e-06 |
0.0001011 |
415 |
REGULATION OF CHEMOTAXIS |
76 |
180 |
9.496e-06 |
0.0001065 |
416 |
CELL CYCLE ARREST |
67 |
154 |
9.59e-06 |
0.0001073 |
417 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
115 |
297 |
9.662e-06 |
0.0001078 |
418 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
110 |
282 |
1.018e-05 |
0.0001131 |
419 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
34 |
64 |
1.018e-05 |
0.0001131 |
420 |
REGULATION OF BMP SIGNALING PATHWAY |
39 |
77 |
1.052e-05 |
0.0001165 |
421 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
88 |
216 |
1.092e-05 |
0.0001207 |
422 |
EXOCYTOSIS |
119 |
310 |
1.097e-05 |
0.000121 |
423 |
MUSCLE CELL DIFFERENTIATION |
95 |
237 |
1.107e-05 |
0.0001217 |
424 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
53 |
115 |
1.113e-05 |
0.0001221 |
425 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
16 |
22 |
1.147e-05 |
0.0001253 |
426 |
SYNAPTIC TRANSMISSION GLUTAMATERGIC |
16 |
22 |
1.147e-05 |
0.0001253 |
427 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
77 |
184 |
1.224e-05 |
0.0001334 |
428 |
CELL GROWTH |
60 |
135 |
1.241e-05 |
0.000135 |
429 |
REGULATION OF CELL AGING |
21 |
33 |
1.312e-05 |
0.0001422 |
430 |
PHOSPHOLIPID BIOSYNTHETIC PROCESS |
94 |
235 |
1.357e-05 |
0.0001468 |
431 |
RESPONSE TO METAL ION |
126 |
333 |
1.384e-05 |
0.0001492 |
432 |
EMBRYONIC PLACENTA DEVELOPMENT |
41 |
83 |
1.385e-05 |
0.0001492 |
433 |
RESPONSE TO OXIDATIVE STRESS |
132 |
352 |
1.462e-05 |
0.0001571 |
434 |
FEMALE SEX DIFFERENTIATION |
53 |
116 |
1.51e-05 |
0.0001619 |
435 |
SPROUTING ANGIOGENESIS |
26 |
45 |
1.562e-05 |
0.0001664 |
436 |
REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS |
42 |
86 |
1.563e-05 |
0.0001664 |
437 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
183 |
514 |
1.561e-05 |
0.0001664 |
438 |
BONE DEVELOPMENT |
67 |
156 |
1.605e-05 |
0.0001705 |
439 |
METAL ION TRANSPORT |
204 |
582 |
1.622e-05 |
0.0001719 |
440 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
28 |
50 |
1.666e-05 |
0.000176 |
441 |
CELL FATE COMMITMENT |
91 |
227 |
1.668e-05 |
0.000176 |
442 |
POSITIVE REGULATION OF ORGAN GROWTH |
23 |
38 |
1.692e-05 |
0.0001781 |
443 |
HIPPOCAMPUS DEVELOPMENT |
37 |
73 |
1.722e-05 |
0.0001809 |
444 |
REGULATION OF JUN KINASE ACTIVITY |
40 |
81 |
1.772e-05 |
0.0001857 |
445 |
NEGATIVE REGULATION OF NEURON DEATH |
72 |
171 |
1.8e-05 |
0.0001883 |
446 |
BONE TRABECULA MORPHOGENESIS |
10 |
11 |
1.845e-05 |
0.0001925 |
447 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
35 |
68 |
1.881e-05 |
0.0001958 |
448 |
AGING |
103 |
264 |
1.896e-05 |
0.0001965 |
449 |
DIGESTIVE SYSTEM DEVELOPMENT |
64 |
148 |
1.895e-05 |
0.0001965 |
450 |
CELL MATURATION |
58 |
131 |
1.975e-05 |
0.0002038 |
451 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
48 |
103 |
1.972e-05 |
0.0002038 |
452 |
REGULATION OF MUSCLE ADAPTATION |
33 |
63 |
2.017e-05 |
0.0002077 |
453 |
POSITIVE REGULATION OF CELL ADHESION |
139 |
376 |
2.024e-05 |
0.0002079 |
454 |
REGULATION OF MITOTIC CELL CYCLE |
168 |
468 |
2.044e-05 |
0.000209 |
455 |
RESPONSE TO MECHANICAL STIMULUS |
85 |
210 |
2.042e-05 |
0.000209 |
456 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT |
27 |
48 |
2.107e-05 |
0.000215 |
457 |
REGULATION OF FAT CELL DIFFERENTIATION |
49 |
106 |
2.125e-05 |
0.0002164 |
458 |
HINDBRAIN DEVELOPMENT |
60 |
137 |
2.145e-05 |
0.0002179 |
459 |
NEURON PROJECTION EXTENSION |
29 |
53 |
2.152e-05 |
0.0002182 |
460 |
POSITIVE REGULATION OF HEART GROWTH |
18 |
27 |
2.164e-05 |
0.0002184 |
461 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS |
18 |
27 |
2.164e-05 |
0.0002184 |
462 |
PHOSPHOLIPID METABOLIC PROCESS |
135 |
364 |
2.206e-05 |
0.0002217 |
463 |
ENDODERM DEVELOPMENT |
36 |
71 |
2.204e-05 |
0.0002217 |
464 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
42 |
87 |
2.231e-05 |
0.0002238 |
465 |
BONE MORPHOGENESIS |
39 |
79 |
2.267e-05 |
0.0002269 |
466 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
34 |
66 |
2.407e-05 |
0.0002398 |
467 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
34 |
66 |
2.407e-05 |
0.0002398 |
468 |
RECEPTOR CLUSTERING |
24 |
41 |
2.451e-05 |
0.0002437 |
469 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
81 |
199 |
2.489e-05 |
0.000247 |
470 |
RESPONSE TO WOUNDING |
197 |
563 |
2.532e-05 |
0.0002507 |
471 |
REGULATION OF PROTEIN DEACETYLATION |
21 |
34 |
2.55e-05 |
0.0002519 |
472 |
SENSORY PERCEPTION OF MECHANICAL STIMULUS |
66 |
155 |
2.576e-05 |
0.0002532 |
473 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
32 |
61 |
2.579e-05 |
0.0002532 |
474 |
GASTRULATION |
66 |
155 |
2.576e-05 |
0.0002532 |
475 |
CATION TRANSPORT |
268 |
796 |
2.63e-05 |
0.0002576 |
476 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
59 |
135 |
2.698e-05 |
0.0002637 |
477 |
REGULATION OF NEUROTRANSMITTER SECRETION |
28 |
51 |
2.737e-05 |
0.0002669 |
478 |
GLYCEROLIPID METABOLIC PROCESS |
132 |
356 |
2.742e-05 |
0.0002669 |
479 |
PLACENTA DEVELOPMENT |
60 |
138 |
2.796e-05 |
0.0002716 |
480 |
TRABECULA FORMATION |
16 |
23 |
2.813e-05 |
0.0002727 |
481 |
SYNAPSE ASSEMBLY |
35 |
69 |
2.823e-05 |
0.000273 |
482 |
STRIATED MUSCLE CELL DIFFERENTIATION |
72 |
173 |
2.874e-05 |
0.0002774 |
483 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
77 |
188 |
3.021e-05 |
0.000291 |
484 |
REGULATION OF AXON GUIDANCE |
23 |
39 |
3.062e-05 |
0.0002944 |
485 |
FORMATION OF PRIMARY GERM LAYER |
50 |
110 |
3.08e-05 |
0.0002955 |
486 |
LIPID PHOSPHORYLATION |
46 |
99 |
3.193e-05 |
0.0003057 |
487 |
REGULATION OF SYNAPSE ORGANIZATION |
51 |
113 |
3.265e-05 |
0.0003116 |
488 |
REGULATION OF REGULATED SECRETORY PATHWAY |
57 |
130 |
3.268e-05 |
0.0003116 |
489 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
136 |
370 |
3.399e-05 |
0.0003227 |
490 |
POSITIVE REGULATION OF SECRETION |
136 |
370 |
3.399e-05 |
0.0003227 |
491 |
REGULATION OF PROTEIN SECRETION |
142 |
389 |
3.422e-05 |
0.000323 |
492 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
68 |
162 |
3.414e-05 |
0.000323 |
493 |
REGULATION OF BLOOD CIRCULATION |
112 |
295 |
3.416e-05 |
0.000323 |
494 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
70 |
168 |
3.521e-05 |
0.0003316 |
495 |
POSITIVE REGULATION OF NEURON DEATH |
34 |
67 |
3.615e-05 |
0.0003383 |
496 |
CELL MATRIX ADHESION |
53 |
119 |
3.621e-05 |
0.0003383 |
497 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
34 |
67 |
3.615e-05 |
0.0003383 |
498 |
MEMBRANE ORGANIZATION |
298 |
899 |
3.618e-05 |
0.0003383 |
499 |
NEURAL CREST CELL DIFFERENTIATION |
37 |
75 |
3.714e-05 |
0.0003463 |
500 |
NEGATIVE REGULATION OF CELL MATRIX ADHESION |
19 |
30 |
3.76e-05 |
0.0003492 |
501 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
19 |
30 |
3.76e-05 |
0.0003492 |
502 |
REGULATION OF MUSCLE SYSTEM PROCESS |
79 |
195 |
3.78e-05 |
0.0003504 |
503 |
IMMUNE SYSTEM PROCESS |
616 |
1984 |
3.838e-05 |
0.0003548 |
504 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
199 |
573 |
3.843e-05 |
0.0003548 |
505 |
NEUROMUSCULAR PROCESS |
45 |
97 |
4.064e-05 |
0.0003744 |
506 |
SECOND MESSENGER MEDIATED SIGNALING |
67 |
160 |
4.249e-05 |
0.0003907 |
507 |
METENCEPHALON DEVELOPMENT |
46 |
100 |
4.365e-05 |
0.0003998 |
508 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
46 |
100 |
4.365e-05 |
0.0003998 |
509 |
NEURONAL ACTION POTENTIAL |
18 |
28 |
4.515e-05 |
0.0004127 |
510 |
GLYCEROLIPID BIOSYNTHETIC PROCESS |
84 |
211 |
4.63e-05 |
0.0004225 |
511 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
36 |
73 |
4.755e-05 |
0.000433 |
512 |
REGULATION OF HORMONE LEVELS |
169 |
478 |
4.972e-05 |
0.0004519 |
513 |
CHONDROCYTE DIFFERENTIATION |
31 |
60 |
5.052e-05 |
0.0004583 |
514 |
SINGLE ORGANISM CELL ADHESION |
163 |
459 |
5.168e-05 |
0.0004678 |
515 |
RESPONSE TO PURINE CONTAINING COMPOUND |
66 |
158 |
5.285e-05 |
0.0004775 |
516 |
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS |
34 |
68 |
5.349e-05 |
0.0004823 |
517 |
CELL JUNCTION ASSEMBLY |
56 |
129 |
5.358e-05 |
0.0004823 |
518 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
29 |
55 |
5.397e-05 |
0.0004848 |
519 |
GLUCOSE HOMEOSTASIS |
70 |
170 |
5.54e-05 |
0.0004954 |
520 |
CARBOHYDRATE HOMEOSTASIS |
70 |
170 |
5.54e-05 |
0.0004954 |
521 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
45 |
98 |
5.547e-05 |
0.0004954 |
522 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
27 |
50 |
5.609e-05 |
0.0004999 |
523 |
ENDOCHONDRAL BONE MORPHOGENESIS |
25 |
45 |
5.619e-05 |
0.0004999 |
524 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
101 |
264 |
5.701e-05 |
0.0005045 |
525 |
CELL JUNCTION ORGANIZATION |
75 |
185 |
5.703e-05 |
0.0005045 |
526 |
RESPONSE TO KETONE |
74 |
182 |
5.683e-05 |
0.0005045 |
527 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
77 |
191 |
5.725e-05 |
0.0005055 |
528 |
APOPTOTIC SIGNALING PATHWAY |
109 |
289 |
5.926e-05 |
0.0005222 |
529 |
ENDOTHELIUM DEVELOPMENT |
42 |
90 |
6.105e-05 |
0.000537 |
530 |
REPRODUCTION |
414 |
1297 |
6.239e-05 |
0.0005477 |
531 |
IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY |
16 |
24 |
6.3e-05 |
0.000552 |
532 |
EMBRYONIC PATTERN SPECIFICATION |
30 |
58 |
6.473e-05 |
0.0005661 |
533 |
INOSITOL LIPID MEDIATED SIGNALING |
54 |
124 |
6.509e-05 |
0.0005683 |
534 |
JNK CASCADE |
39 |
82 |
6.565e-05 |
0.0005721 |
535 |
COLLAGEN FIBRIL ORGANIZATION |
22 |
38 |
6.734e-05 |
0.0005857 |
536 |
NEGATIVE REGULATION OF TRANSPORT |
162 |
458 |
6.865e-05 |
0.000596 |
537 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
28 |
53 |
6.906e-05 |
0.0005984 |
538 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
82 |
207 |
6.932e-05 |
0.0005995 |
539 |
REGULATION OF ION HOMEOSTASIS |
80 |
201 |
6.99e-05 |
0.0006034 |
540 |
CARDIAC SEPTUM DEVELOPMENT |
40 |
85 |
7.175e-05 |
0.0006137 |
541 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
26 |
48 |
7.158e-05 |
0.0006137 |
542 |
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
288 |
873 |
7.139e-05 |
0.0006137 |
543 |
REGULATION OF LIPID KINASE ACTIVITY |
26 |
48 |
7.158e-05 |
0.0006137 |
544 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
40 |
85 |
7.175e-05 |
0.0006137 |
545 |
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION |
15 |
22 |
7.274e-05 |
0.0006199 |
546 |
SUBPALLIUM DEVELOPMENT |
15 |
22 |
7.274e-05 |
0.0006199 |
547 |
REGULATION OF SODIUM ION TRANSPORT |
37 |
77 |
7.617e-05 |
0.0006467 |
548 |
DEVELOPMENTAL CELL GROWTH |
37 |
77 |
7.617e-05 |
0.0006467 |
549 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
349 |
1079 |
7.653e-05 |
0.0006486 |
550 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
34 |
69 |
7.803e-05 |
0.0006601 |
551 |
RENAL SYSTEM PROCESS |
46 |
102 |
7.955e-05 |
0.0006718 |
552 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
29 |
56 |
8.296e-05 |
0.0006993 |
553 |
ADULT LOCOMOTORY BEHAVIOR |
38 |
80 |
8.387e-05 |
0.0007057 |
554 |
POSITIVE REGULATION OF AXON EXTENSION |
21 |
36 |
8.461e-05 |
0.0007093 |
555 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
54 |
125 |
8.452e-05 |
0.0007093 |
556 |
PROTEIN OLIGOMERIZATION |
154 |
434 |
8.573e-05 |
0.0007174 |
557 |
GLIOGENESIS |
71 |
175 |
8.609e-05 |
0.0007192 |
558 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
32 |
64 |
8.789e-05 |
0.0007329 |
559 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
18 |
29 |
8.872e-05 |
0.0007359 |
560 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
18 |
29 |
8.872e-05 |
0.0007359 |
561 |
CARDIAC MUSCLE CELL CONTRACTION |
18 |
29 |
8.872e-05 |
0.0007359 |
562 |
GLANDULAR EPITHELIAL CELL DEVELOPMENT |
13 |
18 |
9.013e-05 |
0.0007462 |
563 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
25 |
46 |
9.136e-05 |
0.0007551 |
564 |
REGULATION OF POTASSIUM ION TRANSPORT |
39 |
83 |
9.155e-05 |
0.0007553 |
565 |
HISTONE H3 K9 MODIFICATION |
11 |
14 |
9.353e-05 |
0.0007702 |
566 |
REGULATION OF ARF PROTEIN SIGNAL TRANSDUCTION |
12 |
16 |
9.475e-05 |
0.000779 |
567 |
ARTERY DEVELOPMENT |
36 |
75 |
9.742e-05 |
0.0007995 |
568 |
CELLULAR RESPONSE TO STARVATION |
51 |
117 |
9.945e-05 |
0.0008147 |
569 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
63 |
152 |
0.0001013 |
0.0008288 |
570 |
REGULATION OF CIRCADIAN RHYTHM |
46 |
103 |
0.0001061 |
0.0008649 |
571 |
CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER |
20 |
34 |
0.0001061 |
0.0008649 |
572 |
SEGMENTATION |
41 |
89 |
0.0001066 |
0.0008671 |
573 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
54 |
126 |
0.0001091 |
0.0008859 |
574 |
TRANSITION METAL ION HOMEOSTASIS |
47 |
106 |
0.0001112 |
0.0009002 |
575 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
47 |
106 |
0.0001112 |
0.0009002 |
576 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
55 |
129 |
0.0001119 |
0.0009039 |
577 |
REGULATION OF NEURONAL SYNAPTIC PLASTICITY |
26 |
49 |
0.0001132 |
0.0009126 |
578 |
GLYCOPROTEIN METABOLIC PROCESS |
128 |
353 |
0.0001136 |
0.0009149 |
579 |
GLANDULAR EPITHELIAL CELL DIFFERENTIATION |
22 |
39 |
0.0001149 |
0.0009231 |
580 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
48 |
109 |
0.0001161 |
0.0009316 |
581 |
INORGANIC ION TRANSMEMBRANE TRANSPORT |
199 |
583 |
0.0001183 |
0.0009477 |
582 |
RESPONSE TO AMINO ACID |
49 |
112 |
0.0001208 |
0.0009654 |
583 |
MULTI MULTICELLULAR ORGANISM PROCESS |
83 |
213 |
0.000122 |
0.0009736 |
584 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
61 |
147 |
0.0001244 |
0.000991 |
585 |
ASSOCIATIVE LEARNING |
35 |
73 |
0.0001246 |
0.0009914 |
586 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
44 |
98 |
0.0001277 |
0.001014 |
587 |
MULTICELLULAR ORGANISM GROWTH |
36 |
76 |
0.0001369 |
0.001086 |
588 |
CARDIAC CHAMBER MORPHOGENESIS |
46 |
104 |
0.0001405 |
0.001106 |
589 |
POSITIVE REGULATION OF PROTEIN IMPORT |
46 |
104 |
0.0001405 |
0.001106 |
590 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
46 |
104 |
0.0001405 |
0.001106 |
591 |
REGULATION OF PROTEIN TARGETING |
113 |
307 |
0.0001404 |
0.001106 |
592 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
140 |
393 |
0.0001433 |
0.001126 |
593 |
NERVE DEVELOPMENT |
33 |
68 |
0.0001439 |
0.001129 |
594 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
30 |
60 |
0.0001446 |
0.001132 |
595 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
41 |
90 |
0.0001447 |
0.001132 |
596 |
LIPID BIOSYNTHETIC PROCESS |
185 |
539 |
0.0001454 |
0.001135 |
597 |
AXON EXTENSION |
21 |
37 |
0.0001456 |
0.001135 |
598 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
56 |
133 |
0.0001458 |
0.001135 |
599 |
DENDRITE MORPHOGENESIS |
23 |
42 |
0.0001488 |
0.001152 |
600 |
REGULATION OF HEART GROWTH |
23 |
42 |
0.0001488 |
0.001152 |
601 |
GLIAL CELL DIFFERENTIATION |
57 |
136 |
0.0001484 |
0.001152 |
602 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
42 |
93 |
0.0001534 |
0.001186 |
603 |
CRANIAL NERVE MORPHOGENESIS |
15 |
23 |
0.0001564 |
0.001207 |
604 |
OVULATION CYCLE |
49 |
113 |
0.0001574 |
0.00121 |
605 |
RESPONSE TO RADIATION |
146 |
413 |
0.0001572 |
0.00121 |
606 |
AMEBOIDAL TYPE CELL MIGRATION |
63 |
154 |
0.0001584 |
0.001216 |
607 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
70 |
175 |
0.0001605 |
0.00123 |
608 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
50 |
116 |
0.0001623 |
0.00124 |
609 |
CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT |
50 |
116 |
0.0001623 |
0.00124 |
610 |
ION TRANSMEMBRANE TRANSPORT |
270 |
822 |
0.0001636 |
0.001248 |
611 |
REGULATION OF CARTILAGE DEVELOPMENT |
31 |
63 |
0.0001644 |
0.00125 |
612 |
POSITIVE REGULATION OF JUN KINASE ACTIVITY |
31 |
63 |
0.0001644 |
0.00125 |
613 |
NEURON MATURATION |
18 |
30 |
0.0001654 |
0.001255 |
614 |
REGULATION OF HEART CONTRACTION |
85 |
221 |
0.0001714 |
0.001299 |
615 |
VISUAL BEHAVIOR |
26 |
50 |
0.000175 |
0.001324 |
616 |
CYTOSOLIC TRANSPORT |
83 |
215 |
0.0001758 |
0.001328 |
617 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
54 |
128 |
0.0001787 |
0.001347 |
618 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
81 |
209 |
0.0001801 |
0.001356 |
619 |
NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
55 |
131 |
0.0001819 |
0.001367 |
620 |
REGULATION OF MICROTUBULE BASED PROCESS |
92 |
243 |
0.000183 |
0.001373 |
621 |
FOREBRAIN GENERATION OF NEURONS |
32 |
66 |
0.0001843 |
0.001375 |
622 |
REGULATION OF MULTICELLULAR ORGANISM GROWTH |
32 |
66 |
0.0001843 |
0.001375 |
623 |
OVULATION CYCLE PROCESS |
40 |
88 |
0.0001839 |
0.001375 |
624 |
MESODERM MORPHOGENESIS |
32 |
66 |
0.0001843 |
0.001375 |
625 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
22 |
40 |
0.0001899 |
0.001411 |
626 |
FORELIMB MORPHOGENESIS |
22 |
40 |
0.0001899 |
0.001411 |
627 |
REGULATION OF CELL CYCLE PROCESS |
190 |
558 |
0.0001931 |
0.001433 |
628 |
HORMONE MEDIATED SIGNALING PATHWAY |
64 |
158 |
0.0001973 |
0.001462 |
629 |
CELLULAR RESPONSE TO AMINO ACID STIMULUS |
27 |
53 |
0.0002063 |
0.001526 |
630 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
94 |
250 |
0.0002083 |
0.001539 |
631 |
MAMMARY GLAND DEVELOPMENT |
50 |
117 |
0.0002092 |
0.001543 |
632 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
30 |
61 |
0.000211 |
0.001553 |
633 |
ENTEROENDOCRINE CELL DIFFERENTIATION |
13 |
19 |
0.000214 |
0.001568 |
634 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
13 |
19 |
0.000214 |
0.001568 |
635 |
REGULATION OF LONG TERM SYNAPTIC POTENTIATION |
13 |
19 |
0.000214 |
0.001568 |
636 |
REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
43 |
97 |
0.0002148 |
0.001572 |
637 |
POST GOLGI VESICLE MEDIATED TRANSPORT |
38 |
83 |
0.0002197 |
0.001605 |
638 |
ENDOTHELIAL CELL DIFFERENTIATION |
34 |
72 |
0.0002238 |
0.001632 |
639 |
NEURON RECOGNITION |
19 |
33 |
0.0002331 |
0.001692 |
640 |
ADULT BEHAVIOR |
56 |
135 |
0.0002329 |
0.001692 |
641 |
REGULATION OF PROTEIN EXPORT FROM NUCLEUS |
19 |
33 |
0.0002331 |
0.001692 |
642 |
POSITIVE REGULATION OF DNA REPLICATION |
39 |
86 |
0.0002336 |
0.001693 |
643 |
PEPTIDYL TYROSINE MODIFICATION |
73 |
186 |
0.0002345 |
0.001697 |
644 |
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION |
23 |
43 |
0.0002379 |
0.001716 |
645 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
23 |
43 |
0.0002379 |
0.001716 |
646 |
REGULATION OF PROTEIN BINDING |
67 |
168 |
0.0002424 |
0.00173 |
647 |
NEGATIVE REGULATION OF AXON EXTENSION |
21 |
38 |
0.0002422 |
0.00173 |
648 |
REGULATION OF RECEPTOR BINDING |
12 |
17 |
0.000242 |
0.00173 |
649 |
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT |
21 |
38 |
0.0002422 |
0.00173 |
650 |
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
35 |
75 |
0.000243 |
0.00173 |
651 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
35 |
75 |
0.000243 |
0.00173 |
652 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
21 |
38 |
0.0002422 |
0.00173 |
653 |
ESTABLISHMENT OF TISSUE POLARITY |
12 |
17 |
0.000242 |
0.00173 |
654 |
NEGATIVE REGULATION OF CELL ADHESION |
85 |
223 |
0.0002431 |
0.00173 |
655 |
RESPONSE TO HYDROGEN PEROXIDE |
47 |
109 |
0.0002487 |
0.001766 |
656 |
REGULATION OF CELLULAR SENESCENCE |
16 |
26 |
0.000254 |
0.001796 |
657 |
REPLACEMENT OSSIFICATION |
16 |
26 |
0.000254 |
0.001796 |
658 |
ENDOCHONDRAL OSSIFICATION |
16 |
26 |
0.000254 |
0.001796 |
659 |
NEPHRON DEVELOPMENT |
49 |
115 |
0.0002622 |
0.001851 |
660 |
VASCULOGENESIS |
29 |
59 |
0.0002708 |
0.001909 |
661 |
CANONICAL WNT SIGNALING PATHWAY |
42 |
95 |
0.0002716 |
0.001912 |
662 |
TYPE B PANCREATIC CELL DEVELOPMENT |
10 |
13 |
0.0002725 |
0.001916 |
663 |
INTRACELLULAR PROTEIN TRANSPORT |
256 |
781 |
0.0002759 |
0.001936 |
664 |
MICROTUBULE BASED PROCESS |
178 |
522 |
0.0002786 |
0.001952 |
665 |
METANEPHROS DEVELOPMENT |
37 |
81 |
0.0002796 |
0.001953 |
666 |
CALCIUM ION REGULATED EXOCYTOSIS |
37 |
81 |
0.0002796 |
0.001953 |
667 |
PROTEIN DEPHOSPHORYLATION |
74 |
190 |
0.0002806 |
0.001957 |
668 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
101 |
274 |
0.0002892 |
0.002015 |
669 |
REGULATION OF BODY FLUID LEVELS |
173 |
506 |
0.0002911 |
0.002025 |
670 |
EYE MORPHOGENESIS |
56 |
136 |
0.0002922 |
0.002029 |
671 |
CELLULAR RESPONSE TO GLUCOSE STARVATION |
18 |
31 |
0.0002943 |
0.002037 |
672 |
REGULATION OF SYNAPTIC VESICLE TRANSPORT |
18 |
31 |
0.0002943 |
0.002037 |
673 |
MACROMOLECULAR COMPLEX ASSEMBLY |
437 |
1398 |
0.0002949 |
0.002039 |
674 |
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
38 |
84 |
0.0002968 |
0.002049 |
675 |
RESPONSE TO STARVATION |
62 |
154 |
0.0002995 |
0.002065 |
676 |
FOREBRAIN CELL MIGRATION |
30 |
62 |
0.000303 |
0.002077 |
677 |
RESPONSE TO EXTRACELLULAR STIMULUS |
153 |
441 |
0.0003018 |
0.002077 |
678 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
30 |
62 |
0.000303 |
0.002077 |
679 |
DIVALENT INORGANIC CATION TRANSPORT |
99 |
268 |
0.0003024 |
0.002077 |
680 |
AORTA DEVELOPMENT |
22 |
41 |
0.0003048 |
0.002077 |
681 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
22 |
41 |
0.0003048 |
0.002077 |
682 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
22 |
41 |
0.0003048 |
0.002077 |
683 |
GLUTAMATE RECEPTOR SIGNALING PATHWAY |
22 |
41 |
0.0003048 |
0.002077 |
684 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
20 |
36 |
0.000309 |
0.002102 |
685 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
15 |
24 |
0.000312 |
0.00212 |
686 |
AXIS SPECIFICATION |
40 |
90 |
0.0003287 |
0.00222 |
687 |
SYNAPTIC VESICLE CYCLE |
40 |
90 |
0.0003287 |
0.00222 |
688 |
RECEPTOR MEDIATED ENDOCYTOSIS |
87 |
231 |
0.0003291 |
0.00222 |
689 |
REGULATION OF GLIOGENESIS |
40 |
90 |
0.0003287 |
0.00222 |
690 |
MESONEPHROS DEVELOPMENT |
40 |
90 |
0.0003287 |
0.00222 |
691 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
25 |
49 |
0.0003408 |
0.002295 |
692 |
RESPONSE TO CORTICOSTEROID |
69 |
176 |
0.0003547 |
0.002385 |
693 |
REGULATION OF PHOSPHATASE ACTIVITY |
53 |
128 |
0.0003558 |
0.002385 |
694 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
36 |
79 |
0.0003558 |
0.002385 |
695 |
NEGATIVE REGULATION OF BINDING |
54 |
131 |
0.0003593 |
0.002405 |
696 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
55 |
134 |
0.0003622 |
0.002422 |
697 |
CIRCADIAN RHYTHM |
56 |
137 |
0.0003646 |
0.002434 |
698 |
ANTIGEN PROCESSING AND PRESENTATION |
81 |
213 |
0.0003651 |
0.002434 |
699 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
298 |
926 |
0.0003657 |
0.002434 |
700 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
97 |
263 |
0.0003682 |
0.002446 |
701 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
59 |
146 |
0.0003685 |
0.002446 |
702 |
NEUROBLAST PROLIFERATION |
17 |
29 |
0.0003708 |
0.002458 |
703 |
MUSCLE SYSTEM PROCESS |
103 |
282 |
0.000372 |
0.002462 |
704 |
CARDIAC CONDUCTION |
37 |
82 |
0.000377 |
0.002492 |
705 |
CEREBRAL CORTEX NEURON DIFFERENTIATION |
14 |
22 |
0.0003804 |
0.002507 |
706 |
EMBRYONIC PLACENTA MORPHOGENESIS |
14 |
22 |
0.0003804 |
0.002507 |
707 |
STEM CELL PROLIFERATION |
29 |
60 |
0.0003888 |
0.002559 |
708 |
COCHLEA DEVELOPMENT |
21 |
39 |
0.0003908 |
0.002565 |
709 |
NEGATIVE CHEMOTAXIS |
21 |
39 |
0.0003908 |
0.002565 |
710 |
PROTEIN DESTABILIZATION |
19 |
34 |
0.0003939 |
0.002578 |
711 |
BRAIN MORPHOGENESIS |
19 |
34 |
0.0003939 |
0.002578 |
712 |
HEART PROCESS |
38 |
85 |
0.0003972 |
0.002596 |
713 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
95 |
258 |
0.0004483 |
0.002925 |
714 |
MAINTENANCE OF CELL NUMBER |
54 |
132 |
0.0004488 |
0.002925 |
715 |
INTRACELLULAR LIPID TRANSPORT |
13 |
20 |
0.0004589 |
0.002982 |
716 |
AXONAL FASCICULATION |
13 |
20 |
0.0004589 |
0.002982 |
717 |
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION |
154 |
448 |
0.0004634 |
0.003007 |
718 |
EXCITATORY POSTSYNAPTIC POTENTIAL |
16 |
27 |
0.0004661 |
0.003021 |
719 |
REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS |
22 |
42 |
0.0004765 |
0.003079 |
720 |
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS |
22 |
42 |
0.0004765 |
0.003079 |
721 |
REGULATION OF AUTOPHAGY |
92 |
249 |
0.0004793 |
0.003089 |
722 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
36 |
80 |
0.000479 |
0.003089 |
723 |
GOLGI VESICLE TRANSPORT |
114 |
319 |
0.0004918 |
0.003165 |
724 |
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION |
83 |
221 |
0.0004925 |
0.003165 |
725 |
CELLULAR LIPID METABOLIC PROCESS |
293 |
913 |
0.0004975 |
0.003193 |
726 |
MICROTUBULE CYTOSKELETON ORGANIZATION |
123 |
348 |
0.0004986 |
0.003195 |
727 |
SALIVARY GLAND DEVELOPMENT |
18 |
32 |
0.000502 |
0.0032 |
728 |
HINDLIMB MORPHOGENESIS |
20 |
37 |
0.0005012 |
0.0032 |
729 |
MATING |
20 |
37 |
0.0005012 |
0.0032 |
730 |
PROXIMAL DISTAL PATTERN FORMATION |
18 |
32 |
0.000502 |
0.0032 |
731 |
REGULATION OF HEART RATE |
38 |
86 |
0.0005267 |
0.003352 |
732 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
12 |
18 |
0.0005457 |
0.00345 |
733 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
12 |
18 |
0.0005457 |
0.00345 |
734 |
PERICARDIUM DEVELOPMENT |
12 |
18 |
0.0005457 |
0.00345 |
735 |
POSITIVE REGULATION OF PROTEIN DEACETYLATION |
12 |
18 |
0.0005457 |
0.00345 |
736 |
OSTEOBLAST DEVELOPMENT |
12 |
18 |
0.0005457 |
0.00345 |
737 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
39 |
89 |
0.0005481 |
0.003458 |
738 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
77 |
203 |
0.0005484 |
0.003458 |
739 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
29 |
61 |
0.0005499 |
0.003463 |
740 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
59 |
148 |
0.0005571 |
0.003503 |
741 |
RESPONSE TO ORGANOPHOSPHORUS |
56 |
139 |
0.0005596 |
0.003509 |
742 |
REGULATION OF CELL SHAPE |
56 |
139 |
0.0005596 |
0.003509 |
743 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
91 |
247 |
0.000571 |
0.003576 |
744 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
26 |
53 |
0.0005743 |
0.003592 |
745 |
PROTEIN N LINKED GLYCOSYLATION |
34 |
75 |
0.0005762 |
0.003598 |
746 |
STARTLE RESPONSE |
15 |
25 |
0.000584 |
0.003643 |
747 |
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
42 |
98 |
0.0006026 |
0.003753 |
748 |
MAMMARY GLAND MORPHOGENESIS |
21 |
40 |
0.0006129 |
0.003808 |
749 |
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
21 |
40 |
0.0006129 |
0.003808 |
750 |
LIPID MODIFICATION |
79 |
210 |
0.0006256 |
0.003881 |
751 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
11 |
16 |
0.0006361 |
0.003931 |
752 |
STRIATUM DEVELOPMENT |
11 |
16 |
0.0006361 |
0.003931 |
753 |
SINGLE ORGANISM CATABOLIC PROCESS |
305 |
957 |
0.0006349 |
0.003931 |
754 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
27 |
56 |
0.0006407 |
0.003933 |
755 |
NEURON NEURON SYNAPTIC TRANSMISSION |
27 |
56 |
0.0006407 |
0.003933 |
756 |
MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
17 |
30 |
0.0006394 |
0.003933 |
757 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
17 |
30 |
0.0006394 |
0.003933 |
758 |
OUTFLOW TRACT MORPHOGENESIS |
27 |
56 |
0.0006407 |
0.003933 |
759 |
CELL AGING |
31 |
67 |
0.0006463 |
0.003961 |
760 |
POSITIVE REGULATION OF PROTEOLYSIS |
127 |
363 |
0.0006469 |
0.003961 |
761 |
PROTEIN LOCALIZATION TO MEMBRANE |
131 |
376 |
0.0006497 |
0.003972 |
762 |
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
24 |
48 |
0.0006519 |
0.003976 |
763 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT |
24 |
48 |
0.0006519 |
0.003976 |
764 |
REGULATION OF DEPHOSPHORYLATION |
62 |
158 |
0.0006667 |
0.004055 |
765 |
CYTOKINESIS |
37 |
84 |
0.0006664 |
0.004055 |
766 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
60 |
152 |
0.0006765 |
0.004109 |
767 |
NEURAL TUBE DEVELOPMENT |
59 |
149 |
0.0006805 |
0.004128 |
768 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
53 |
131 |
0.000689 |
0.004168 |
769 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
55 |
137 |
0.0006895 |
0.004168 |
770 |
INTERACTION WITH HOST |
54 |
134 |
0.0006897 |
0.004168 |
771 |
VESICLE ORGANIZATION |
101 |
280 |
0.000693 |
0.004177 |
772 |
RESPONSE TO LIGHT STIMULUS |
101 |
280 |
0.000693 |
0.004177 |
773 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
10 |
14 |
0.00072 |
0.004329 |
774 |
POST EMBRYONIC ORGAN DEVELOPMENT |
10 |
14 |
0.00072 |
0.004329 |
775 |
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
14 |
23 |
0.0007288 |
0.004376 |
776 |
ACTIN FILAMENT BASED MOVEMENT |
40 |
93 |
0.0007374 |
0.004418 |
777 |
NEURAL CREST CELL MIGRATION |
25 |
51 |
0.0007387 |
0.004418 |
778 |
NEGATIVE REGULATION OF CHEMOTAXIS |
25 |
51 |
0.0007387 |
0.004418 |
779 |
MITOTIC NUCLEAR DIVISION |
126 |
361 |
0.0007522 |
0.004493 |
780 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
42 |
99 |
0.0007741 |
0.004618 |
781 |
NEGATIVE REGULATION OF RECEPTOR BINDING |
9 |
12 |
0.0007787 |
0.004639 |
782 |
ODONTOGENESIS |
44 |
105 |
0.0008029 |
0.004777 |
783 |
NEGATIVE REGULATION OF PROTEIN BINDING |
35 |
79 |
0.0008093 |
0.004803 |
784 |
REGULATION OF SYNAPSE ASSEMBLY |
35 |
79 |
0.0008093 |
0.004803 |
785 |
GLUTAMATE SECRETION |
16 |
28 |
0.0008136 |
0.004804 |
786 |
REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
16 |
28 |
0.0008136 |
0.004804 |
787 |
MAMMARY GLAND DUCT MORPHOGENESIS |
16 |
28 |
0.0008136 |
0.004804 |
788 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
16 |
28 |
0.0008136 |
0.004804 |
789 |
NEGATIVE REGULATION OF JNK CASCADE |
18 |
33 |
0.0008248 |
0.004858 |
790 |
EMBRYONIC EYE MORPHOGENESIS |
18 |
33 |
0.0008248 |
0.004858 |
791 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
47 |
114 |
0.0008324 |
0.004896 |
792 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
48 |
117 |
0.0008388 |
0.004921 |
793 |
CEREBELLAR CORTEX DEVELOPMENT |
23 |
46 |
0.0008397 |
0.004921 |
794 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
23 |
46 |
0.0008397 |
0.004921 |
795 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
54 |
135 |
0.0008488 |
0.004946 |
796 |
REGULATION OF WOUND HEALING |
51 |
126 |
0.0008495 |
0.004946 |
797 |
WOUND HEALING |
159 |
470 |
0.0008482 |
0.004946 |
798 |
TUBE FORMATION |
52 |
129 |
0.0008504 |
0.004946 |
799 |
MONOVALENT INORGANIC CATION HOMEOSTASIS |
50 |
123 |
0.0008474 |
0.004946 |
800 |
ENDOCRINE SYSTEM DEVELOPMENT |
50 |
123 |
0.0008474 |
0.004946 |
801 |
ORGAN GROWTH |
31 |
68 |
0.0008811 |
0.005118 |
802 |
ESTABLISHMENT OF CELL POLARITY |
38 |
88 |
0.0009021 |
0.005234 |
803 |
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
13 |
21 |
0.0009045 |
0.005235 |
804 |
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS |
13 |
21 |
0.0009045 |
0.005235 |
805 |
DORSAL VENTRAL PATTERN FORMATION |
39 |
91 |
0.0009274 |
0.005361 |
806 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
21 |
41 |
0.0009364 |
0.005399 |
807 |
LUNG ALVEOLUS DEVELOPMENT |
21 |
41 |
0.0009364 |
0.005399 |
808 |
NEURAL TUBE FORMATION |
40 |
94 |
0.00095 |
0.005471 |
809 |
CELL CYCLE CHECKPOINT |
73 |
194 |
0.0009737 |
0.0056 |
810 |
REGULATION OF GLUCOSE IMPORT |
28 |
60 |
0.0009819 |
0.00564 |
811 |
SYNAPTIC VESICLE LOCALIZATION |
44 |
106 |
0.001015 |
0.005801 |
812 |
REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
19 |
36 |
0.001016 |
0.005801 |
813 |
CARDIAC VENTRICLE DEVELOPMENT |
44 |
106 |
0.001015 |
0.005801 |
814 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
79 |
213 |
0.001013 |
0.005801 |
815 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
19 |
36 |
0.001016 |
0.005801 |
816 |
NEGATIVE REGULATION OF MAPK CASCADE |
57 |
145 |
0.00102 |
0.005817 |
817 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
34 |
77 |
0.001026 |
0.005834 |
818 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
34 |
77 |
0.001026 |
0.005834 |
819 |
HEART TRABECULA MORPHOGENESIS |
15 |
26 |
0.001034 |
0.005875 |
820 |
REGULATION OF CELL CELL ADHESION |
131 |
380 |
0.001038 |
0.005891 |
821 |
RESPONSE TO ETHANOL |
54 |
136 |
0.00104 |
0.005892 |
822 |
GLYCOSYLATION |
96 |
267 |
0.001042 |
0.005899 |
823 |
REGULATION OF PROTEIN KINASE B SIGNALING |
49 |
121 |
0.001048 |
0.005925 |
824 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
162 |
482 |
0.001051 |
0.005937 |
825 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
29 |
63 |
0.001055 |
0.005951 |
826 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
17 |
31 |
0.001058 |
0.005963 |
827 |
LABYRINTHINE LAYER DEVELOPMENT |
22 |
44 |
0.001082 |
0.00609 |
828 |
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION |
133 |
387 |
0.001095 |
0.006153 |
829 |
REGULATION OF PROTEIN POLYMERIZATION |
66 |
173 |
0.001099 |
0.006169 |
830 |
ORGAN REGENERATION |
36 |
83 |
0.001103 |
0.006184 |
831 |
REGENERATION |
62 |
161 |
0.001165 |
0.00652 |
832 |
EPITHELIAL CELL PROLIFERATION |
38 |
89 |
0.001166 |
0.00652 |
833 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
79 |
214 |
0.001183 |
0.006611 |
834 |
MYELOID CELL DIFFERENTIATION |
71 |
189 |
0.001193 |
0.006655 |
835 |
ANATOMICAL STRUCTURE MATURATION |
20 |
39 |
0.001208 |
0.006731 |
836 |
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
23 |
47 |
0.001224 |
0.006815 |
837 |
NEGATIVE REGULATION OF WOUND HEALING |
27 |
58 |
0.001258 |
0.006984 |
838 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
55 |
140 |
0.001258 |
0.006984 |
839 |
RESPONSE TO CAMP |
43 |
104 |
0.001265 |
0.007005 |
840 |
MICROTUBULE BASED MOVEMENT |
76 |
205 |
0.001264 |
0.007005 |
841 |
AMINOGLYCAN BIOSYNTHETIC PROCESS |
44 |
107 |
0.001275 |
0.007057 |
842 |
PROTEIN POLYUBIQUITINATION |
88 |
243 |
0.001282 |
0.007084 |
843 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
49 |
122 |
0.001294 |
0.007145 |
844 |
REGULATION OF HISTONE DEACETYLATION |
14 |
24 |
0.001312 |
0.007201 |
845 |
POSITIVE REGULATION OF SODIUM ION TRANSPORT |
18 |
34 |
0.001309 |
0.007201 |
846 |
POSITIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
14 |
24 |
0.001312 |
0.007201 |
847 |
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS |
14 |
24 |
0.001312 |
0.007201 |
848 |
POSITIVE REGULATION OF ATP METABOLIC PROCESS |
14 |
24 |
0.001312 |
0.007201 |
849 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
119 |
343 |
0.001324 |
0.007256 |
850 |
REGULATION OF DOPAMINE METABOLIC PROCESS |
11 |
17 |
0.001359 |
0.007353 |
851 |
REGULATION OF COENZYME METABOLIC PROCESS |
24 |
50 |
0.001361 |
0.007353 |
852 |
ANATOMICAL STRUCTURE ARRANGEMENT |
11 |
17 |
0.001359 |
0.007353 |
853 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
28 |
61 |
0.001348 |
0.007353 |
854 |
REGULATION OF ENERGY HOMEOSTASIS |
11 |
17 |
0.001359 |
0.007353 |
855 |
NEGATIVE REGULATION OF CELL AGING |
11 |
17 |
0.001359 |
0.007353 |
856 |
STEM CELL DIVISION |
16 |
29 |
0.001359 |
0.007353 |
857 |
VACUOLE ORGANIZATION |
64 |
168 |
0.00135 |
0.007353 |
858 |
ENDODERM FORMATION |
24 |
50 |
0.001361 |
0.007353 |
859 |
REGULATION OF COFACTOR METABOLIC PROCESS |
24 |
50 |
0.001361 |
0.007353 |
860 |
REGULATION OF CATECHOLAMINE METABOLIC PROCESS |
11 |
17 |
0.001359 |
0.007353 |
861 |
SOMITE DEVELOPMENT |
34 |
78 |
0.001348 |
0.007353 |
862 |
REGULATION OF FIBROBLAST PROLIFERATION |
35 |
81 |
0.001392 |
0.007503 |
863 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
35 |
81 |
0.001392 |
0.007503 |
864 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
21 |
42 |
0.001396 |
0.007511 |
865 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
21 |
42 |
0.001396 |
0.007511 |
866 |
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS |
195 |
595 |
0.001405 |
0.007548 |
867 |
REGULATION OF ACTIN FILAMENT LENGTH |
60 |
156 |
0.001434 |
0.007695 |
868 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
25 |
53 |
0.00149 |
0.007987 |
869 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
30 |
67 |
0.001511 |
0.008088 |
870 |
NEPHRON EPITHELIUM DEVELOPMENT |
39 |
93 |
0.00152 |
0.008131 |
871 |
CORONARY VASCULATURE DEVELOPMENT |
19 |
37 |
0.001559 |
0.008302 |
872 |
REGULATION OF MUSCLE HYPERTROPHY |
19 |
37 |
0.001559 |
0.008302 |
873 |
REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
19 |
37 |
0.001559 |
0.008302 |
874 |
CAMP MEDIATED SIGNALING |
19 |
37 |
0.001559 |
0.008302 |
875 |
OSTEOBLAST DIFFERENTIATION |
50 |
126 |
0.001583 |
0.008391 |
876 |
NEURAL PRECURSOR CELL PROLIFERATION |
31 |
70 |
0.001582 |
0.008391 |
877 |
EXOCRINE SYSTEM DEVELOPMENT |
22 |
45 |
0.001578 |
0.008391 |
878 |
RESPONSE TO UV |
50 |
126 |
0.001583 |
0.008391 |
879 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
49 |
123 |
0.00159 |
0.008419 |
880 |
POSITIVE REGULATION OF ENDOCYTOSIS |
46 |
114 |
0.001599 |
0.008446 |
881 |
REGULATION OF RECEPTOR ACTIVITY |
47 |
117 |
0.001599 |
0.008446 |
882 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
10 |
15 |
0.001632 |
0.008553 |
883 |
GABAERGIC NEURON DIFFERENTIATION |
10 |
15 |
0.001632 |
0.008553 |
884 |
MORPHOGENESIS OF AN EPITHELIAL FOLD |
10 |
15 |
0.001632 |
0.008553 |
885 |
LONG TERM SYNAPTIC DEPRESSION |
10 |
15 |
0.001632 |
0.008553 |
886 |
NOSE DEVELOPMENT |
10 |
15 |
0.001632 |
0.008553 |
887 |
REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY |
10 |
15 |
0.001632 |
0.008553 |
888 |
CELLULAR RESPONSE TO STEROL |
10 |
15 |
0.001632 |
0.008553 |
889 |
PANCREAS DEVELOPMENT |
32 |
73 |
0.001646 |
0.008605 |
890 |
REGULATION OF PLASMA MEMBRANE ORGANIZATION |
32 |
73 |
0.001646 |
0.008605 |
891 |
REGULATION OF CELLULAR EXTRAVASATION |
13 |
22 |
0.001662 |
0.008677 |
892 |
POSITIVE REGULATION OF TRANSPORTER ACTIVITY |
33 |
76 |
0.001704 |
0.008876 |
893 |
EXTRACELLULAR MATRIX DISASSEMBLY |
33 |
76 |
0.001704 |
0.008876 |
894 |
MOTOR NEURON AXON GUIDANCE |
15 |
27 |
0.001744 |
0.009068 |
895 |
NEGATIVE REGULATION OF AXON GUIDANCE |
15 |
27 |
0.001744 |
0.009068 |
896 |
DIGESTIVE TRACT MORPHOGENESIS |
23 |
48 |
0.001751 |
0.009093 |
897 |
ERBB SIGNALING PATHWAY |
34 |
79 |
0.001755 |
0.009103 |
898 |
MALE SEX DIFFERENTIATION |
57 |
148 |
0.00179 |
0.009273 |
899 |
APICAL JUNCTION ASSEMBLY |
20 |
40 |
0.001803 |
0.0093 |
900 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
20 |
40 |
0.001803 |
0.0093 |
901 |
ENDOCRINE PANCREAS DEVELOPMENT |
20 |
40 |
0.001803 |
0.0093 |
902 |
ENDODERMAL CELL DIFFERENTIATION |
20 |
40 |
0.001803 |
0.0093 |
903 |
RESPONSE TO IONIZING RADIATION |
56 |
145 |
0.001814 |
0.009345 |
904 |
ENDOSOME ORGANIZATION |
28 |
62 |
0.001827 |
0.009385 |
905 |
SOMITOGENESIS |
28 |
62 |
0.001827 |
0.009385 |
906 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
28 |
62 |
0.001827 |
0.009385 |
907 |
REGULATION OF STEM CELL PROLIFERATION |
37 |
88 |
0.001873 |
0.009609 |
908 |
ENSHEATHMENT OF NEURONS |
38 |
91 |
0.001901 |
0.009733 |
909 |
AXON ENSHEATHMENT |
38 |
91 |
0.001901 |
0.009733 |
910 |
POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
9 |
13 |
0.001918 |
0.009784 |
911 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
24 |
51 |
0.001914 |
0.009784 |
912 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE |
9 |
13 |
0.001918 |
0.009784 |
913 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
50 |
127 |
0.00193 |
0.009839 |
914 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
47 |
118 |
0.001965 |
0.009992 |
915 |
MESODERM DEVELOPMENT |
47 |
118 |
0.001965 |
0.009992 |